tetano
Editor, Senior Moderator
Emerg Infect Dis
. 2020 Jul 6;26(9).
doi: 10.3201/eid2609.202144. Online ahead of print.
Retrospective Description of Pregnant Women Infected With Severe Acute Respiratory Syndrome Coronavirus 2, France
Alexandre J Vivanti, J?r?mie Mattern, Christelle Vauloup-Fellous, Jacques Jani, Luc Rigonnot, Larissa El Hachem, Agn?s Le Gouez, C?line Desconclois, Imane Ben M'Barek, Jeanne Sibiude, Alexandra Benachi, Olivier Picone, Anne-Ga?l Cordier
Abstract
Little data are available on the management of pregnant women infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We conducted a retrospective study of 100 pregnant women with SARS-CoV-2 infection in 4 obstetric units in the Paris metropolitan area of France during March 12-April 13, 2020. Among patients, 52 (52%) were hospitalized, 10 (10%) in intensive care units (ICUs). Women with higher body mass indexes (BMIs; median 30.7 kg/m[SUP]2[/SUP]) were more likely to be hospitalized in ICUs than other women (median BMI 26.2 kg/m[SUP]2[/SUP]). Women hospitalized in ICUs had lower lymphocyte count at diagnosis (median 0.77 ? 10[SUP]9[/SUP] cells/L) than women not hospitalized in ICUs (median lymphocyte count 1.15 ? 10[SUP]9[/SUP] cells/L). All women requiring oxygen >5 L/min were intubated. Clinical and laboratory evaluation of SARS-CoV-2-positive pregnant women at the time of diagnosis can identify patients at risk for ICU hospitalization.
Keywords: COVID-19; France; MERS; SARS; SARS-CoV-2; coronavirus; coronavirus disease; pregnancy; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
. 2020 Jul 6;26(9).
doi: 10.3201/eid2609.202144. Online ahead of print.
Retrospective Description of Pregnant Women Infected With Severe Acute Respiratory Syndrome Coronavirus 2, France
Alexandre J Vivanti, J?r?mie Mattern, Christelle Vauloup-Fellous, Jacques Jani, Luc Rigonnot, Larissa El Hachem, Agn?s Le Gouez, C?line Desconclois, Imane Ben M'Barek, Jeanne Sibiude, Alexandra Benachi, Olivier Picone, Anne-Ga?l Cordier
- PMID: 32633712
- DOI: 10.3201/eid2609.202144
Abstract
Little data are available on the management of pregnant women infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We conducted a retrospective study of 100 pregnant women with SARS-CoV-2 infection in 4 obstetric units in the Paris metropolitan area of France during March 12-April 13, 2020. Among patients, 52 (52%) were hospitalized, 10 (10%) in intensive care units (ICUs). Women with higher body mass indexes (BMIs; median 30.7 kg/m[SUP]2[/SUP]) were more likely to be hospitalized in ICUs than other women (median BMI 26.2 kg/m[SUP]2[/SUP]). Women hospitalized in ICUs had lower lymphocyte count at diagnosis (median 0.77 ? 10[SUP]9[/SUP] cells/L) than women not hospitalized in ICUs (median lymphocyte count 1.15 ? 10[SUP]9[/SUP] cells/L). All women requiring oxygen >5 L/min were intubated. Clinical and laboratory evaluation of SARS-CoV-2-positive pregnant women at the time of diagnosis can identify patients at risk for ICU hospitalization.
Keywords: COVID-19; France; MERS; SARS; SARS-CoV-2; coronavirus; coronavirus disease; pregnancy; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.